VarmX
VarmX B.V. is manufacturing therapeutic proteins to instantaneously restore blood clotting in bleeding patients.
VarmX operates in manufacturing, pharmaceutical, therapeutics based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2016.
Its activity falls under manufacturing, pharmaceutical, therapeutics; the profile below is assembled from public directory data.
The business is associated with European Union (EU), Europe, Middle East, and Africa (EMEA).
Directory data places it at the Series_B stage.
Its team size is recorded as c_00001_00010 employees.
Public records show total funding of about $109.6M.
| Sector | Manufacturing, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2016 |
| Employees | c_00001_00010 |
| Stage | series_b |
| Total funding | $109,576,326 |
Website: www.varmx.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account